Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInventory AverageInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Unicycive Therapeutics (UNCY) Times Interest Earned (2020 - 2025)

Unicycive Therapeutics filings provide 3 years of Times Interest Earned readings, the most recent being -$463.05 for Q4 2024.

  • On a quarterly basis, Times Interest Earned fell 39.36% to -$463.05 in Q4 2024 year-over-year; TTM through Dec 2024 was -$452.35, a 76.37% decrease, with the full-year FY2025 number at -$415.73, up 8.1% from a year prior.
  • Times Interest Earned hit -$463.05 in Q4 2024 for Unicycive Therapeutics, down from -$416.73 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$135.06 in Q2 2023 to a low of -$1851.3 in Q3 2022.
  • Median Times Interest Earned over the past 3 years was -$438.47 (2024), compared with a mean of -$657.63.
  • Biggest five-year swings in Times Interest Earned: skyrocketed 82.18% in 2023 and later crashed 242.48% in 2024.
  • Unicycive Therapeutics' Times Interest Earned stood at -$1775.0 in 2022, then soared by 81.28% to -$332.26 in 2023, then plummeted by 39.36% to -$463.05 in 2024.
  • The last three reported values for Times Interest Earned were -$463.05 (Q4 2024), -$416.73 (Q3 2024), and -$462.56 (Q2 2024) per Business Quant data.